Avectas

Avectas is a cell engineering technology company focused on facilitating the manufacture of engineered cell therapies for drug developers. Its platform allows for the ex-vivo modification of various cell types, including T cells for immuno-oncology applications, by permeabilizing cell membranes to enable efficient transfer of advanced molecules such as mRNA, proteins, and gene editing tools. This innovative approach contrasts with traditional vector-free delivery methods, as it maintains high levels of cell viability and functionality while eliminating the need for recovery time. As a result, Avectas' technology streamlines the process of producing potent engineered cell therapies at therapeutic volumes, enhancing efficiency and reducing costs for developers in the cell therapy market.